Law360, New York (July 19, 2010, 5:37 PM ET) -- Novartis Pharmaceuticals Corp. has won its bid to apply New Jersey law to the plaintiffs' claims for punitive damages in two product liability suits accusing the drugmaker of failing to adequately warn that its bone cancer drugs Aredia and Zometa could cause jawbone deterioration.
Judge Arthur D. Spatt of the U.S. District Court for the Eastern District of New York on Friday resolved the parties' dispute over whether New York or New Jersey law on punitive damages should be applied in these suits, ruling that the...
Novartis Wins Punitive Damages Ruling In Aredia Suits
To view the full article, take a free trial now.
